pharma-company /Medicinal products /Active ingredients

Rx · PZN 10948728

HARVONI 90 mg/400 mg film-coated tablets

German trade nameHARVONI 90 mg-400 mg Filmtabletten

Active ingredientSofosbuvir and ledipasvirSubstance (DE)Sofosbuvir und LedipasvirPharmaceutical formFilm-coated tablets

Only sporadically available

0.5

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026

Highest known
purchase price (B2B)

~ €12,188

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for HARVONI 90 mg/400 mg film-coated tablets.

Review purchasing terms

HARVONI 90 mg/400 mg film-coated tablets contains the active ingredient Sofosbuvir and ledipasvir (German Sofosbuvir und Ledipasvir) and comes as Film-coated tablets. One pack size is recorded (PZN 10948728). The pharma availability index for German wholesale stands at 0.5 out of 10 over the past 30 days – the pack was therefore only sporadically available.

HARVONI 90 mg/400 mg film-coated tablets was only sporadically procurable in the past 30 days. We help you identify additional sources of supply and alternative products.

Request a source of supply

More products containing Sofosbuvir and ledipasvir

HARVONI 33,75 mg/150 mg befilmtes granules in sachet0.0HARVONI 45 mg/200 mg befilmtes granules in sachet0.0HARVONI 45 mg/200 mg film-coated tablets0.0
Active ingredient overview: Sofosbuvir and ledipasvir →

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.